RevBio Awarded $2 Million Research Grant to Reduce Opioid Use with Tetranite Bone Adhesive Biomaterial | Image Credit: © RevBio, Inc.

In the hopes of reducing the need for opioids prescribed in tandem with wisdom tooth extractions, RevBio, Inc., has received a grant from the National Institutes of Health through its Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative, to improve strategies for the prevention and treatment of opioid misuse and addiction.

Announced on Wednesday, this $2 million Phase II Small Business Innovation Research (SBIR) grant (2R44DE029369-02) will fund the pre-clinical development of a dental bone graft formulation that will include the release of locally acting non-opioid pain medication. This product is intended to be used to ﬁll extraction sites and mitigate post-operative pain following the removal of wisdom teeth.

“Data shows that there is a statistically signiﬁcant absolute risk increase in persistent opioid use and abuse following a single course of opiates prescribed after wisdom tooth extractions,” George Kay, DMD, MMSc, RevBio’s Chief Scientiﬁc Oﬃcer and co-principal investigator, says in a press release.

Approximately 10 million third molars (wisdom teeth) are removed annually in the United States.1

“Preliminary studies have shown that medication can be incorporated into our patented Tetranite® bone adhesive biomaterial and released over time,” Rahul Jadia, PhD, who is RevBio’s R&D Manager of Technology Development and co-principal investigator for this grant, adds in the press release, “and the release proﬁle of a target drug can be tailored to elicit an ideal time-dose curve.”

Previously, both Drs Kay and Jadia served as co-principal investigators on a Phase I SBIR grant(

) which investigated the release of pain management medication from RevBio’s adhesive dental bone scaﬀold. Their research was highlighted in a feature story, and for more information click here to visit the 

National Institute of Health’s HEAL Initiative website. 

Opioid use disorder (OUD) is a major problem in the US, accounting for 107,622 overdose deaths in 2021.

It has always been common for opioids to be prescribed after many routine dental surgeries. A major factor contributing to widespread OUD is post-operative opioid prescription following routine dental surgeries such as wisdom tooth extraction.

 Finding an alternative to opioid prescription is extremely important since most patients who undergo wisdom tooth extractions are between the ages of 13 and 30 and are highly susceptible to OUD.

A recent study conducted on almost 71,000 patients showed that approximately 79.9% of patients ﬁlled perioperative opioid prescriptions for wisdom tooth extractions.

 In a similar study conducted on a larger sample—more than 750,000 individuals—there was a statistically significant 6.8% absolute increase in persistent opioid use and a 5.4% increase in the subsequent diagnosis of opioid abuse.

These studies highlight a compelling need for the development of non-opioid-based acute pain management strategies for dental patients undergoing outpatient oral surgery procedures, preferably via the local delivery of medications to target tissues.

In addition to the pain from the surgery, 10% of all wisdom tooth extraction sites develop a painful condition known as “dry socket” which can occur 3 to 4 days after a wisdom tooth is removed.

 This condition develops when the blood clot that should form after a tooth extraction is dislodged or dissolves before the wound heals, exposing underlying bone and nerves.

“Not only will Tetranite locally release pain medication, avoiding the need for a potentially addictive prescription, but the material will occlude the socket and reduce the potential for dry socket,” says Dr Kay in the press release.

This grant complements the existing funding that RevBio has received from the NIH-funded Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center (U24DE0294162) which was formed to improve the translation of promising tissue engineering and regenerative medicine technologies for dental, oral, and craniofacial clinical practice. This latest grant also expands upon a Phase II SBIR grant (

) which the company received from the National Institute of Dental and Cranial Research (NIDCR).

RevBio, Inc., is a clinical stage medical device company engaged in the development and commercialization of Tetranite, a patented, synthetic, injectable, self-setting, and osteoconductive bone adhesive biomaterial. The company is initially developing this technology for use in the dental, cranial, and broader orthopaedic markets as well as applications in the animal health market. RevBio's Tetranite technology is not yet approved for commercial use.

1. Centers for Disease Control and Prevention. "US Overdose Deaths In 2021 Increased Half as Much as in 2020–But Are Still Up 15%." Accessed August 16 (2022): 2022.

2. Wampler, AE. "Opioids and Dentistry." 

3. Richard, P., Bauer, M R, Moresco, N., Walker, R., Bowser, D., Reed, D., and Larson, MJ. "Opioid prescribing for surgical dental procedures in dental clinics of military treatment facilities." The Journal of the American Dental Association 152, no. 2 (2021): 94-104.

4. Akinbami, BO., and Godspower, T. "Dry socket: incidence, clinical features, and predisposing factors." International journal of dentistry 2014(2014).

5. Coulthard, P., Bailey, E., Esposito, M., Furness, S., Renton, T F, and Worthington, H V. "Surgical techniques for the removal of mandibular wisdom teeth."

Articles

The latest grant will extend the research conducted and further enhance the company’s dental bone graft solution with the localized release of non-opioid pain medications to reduce the need for opioids prescribed in conjunction with wisdom tooth extractions.

RevBio Awarded $2 Million Research Grant to Reduce Opioid Use with Tetranite Bone Adhesive Biomaterial

New ADA Forsyth Institute Looks to Pioneer Excellence in Oral Health Research and Innovation | Image Credit: © ADA

The American Dental Association (ADA) and the Forsyth Institute just announced the establishment of the ADA Forsyth Institute, a powerhouse of unrivaled expertise, visionary research opportunities, and dynamic innovation prospects, all dedicated to propelling the field of oral health through groundbreaking scientific innovation and research.

Massachusetts Governor Maura Healey expressed her enthusiasm for this development, stating in a press release, “The new ADA Forsyth Institute will continue to advance oral and overall health through ground-breaking research and innovation. The Forsyth Institute has been, and will continue to be, an integral part of the Massachusetts bio-innovation and research community. This new venture will build on more than a century of excellent work right here in Massachusetts, including the discovery of how ﬂuoride prevents cavities.”

The momentous announcement was made Thursday by ADA Chief Executive Officer, Raymond Cohlmia, DDS, and Forsyth Institute Chair of the Board, Elyse Cherry, during the Forsyth dentech annual innovation conference in Somerville, Mass. This conference serves as a gathering point for thought leaders from government, research, industry, academia, and venture capital, all coming together to expedite innovation and launch groundbreaking initiatives in the realm of oral health.

Dr. Wenyuan Shi, PhD, President and CEO of the Forsyth Institute, emphasizes in the press release, “The new Institute will be a world-class leader in dentistry, deﬁning the future of oral health through biological research, local and global public health outreach, and technological innovation. The positive impact will be felt globally.”

The ADA Forsyth Institute, under the leadership of Dr Shi in Boston, commences its transformative work immediately.

“This is a historic and exciting day for champions of oral health,” declares Cherry in the press release. “We believe the ADA Forsyth Institute will accelerate the pace of scientific discovery and innovation for generations to come.”

The ADA Forsyth Institute merges the ADA Science & Research Institute and the Forsyth Institute, promising to revolutionize the landscape of oral health research and innovation.

Dr Cohlmia elaborates by saying in the press release, “This will immediately change the landscape for health research and innovation. Oral health is integral to overall health, and this combination of mindshare will bring technology and health care advances to patients at a global scale. Together, we will improve lives through transformative research that starts in the lab and ends with improving patient care in the dental chair.”

Founded in 1910, the Forsyth Institute originated as a philanthropic endeavor, providing dental care to children in the Boston area, and evolved into a vanguard in biomedical research. Among its notable achievements are the development of the first local antibiotic for treating gum disease and the discovery of the bacteria responsible for cavities. Additionally, the Forsyth Institute provides oral healthcare through mobile, private practice, and global programs.

The ADA Forsyth Institute will occupy the forefront of research while continuing the valuable work initiated by ADASRI to date, including the creation of the first comprehensive map of every cell in the oral cavity, the establishment of Food and Drug Administration-recognized standards for nearly every dental tool, the formulation of evidence-based guidelines for patient treatment, and the ADA Seal of Acceptance program, renowned for its rigorous product evaluation criteria trusted by dental professionals and consumers alike. To date, over 400 products have earned this prestigious Seal, signifying their safety and effectiveness.

Linda Edgar, DDS, president of the ADA, exclaims in the press release, “This is an incredible opportunity to advance the aligned missions of the ADA and Forsyth. The Forsyth Institute has along and storied history of scientific leadership and a dedication to making people healthier. Looking toward the future, we’re excited to see the many ways the ADA Forsyth Institute will carry on that legacy.”

The ADA, a not-for-profit organization, stands as the nation's largest dental association, representing 159,000 dentist members. Serving as the primary source of oral health information, the ADA has been advocating for public health and promoting the art and science of dentistry since 1859. The ADA's state-of-the-art research facilities have been instrumental in developing and testing dental products and materials, significantly enhancing the practice of dentistry and improving the patient experience.

The Forsyth Institute, established in 1910, stands as the world’s foremost independent research institution dedicated to oral health and its relationship to overall well-being. Originating as a pediatric dental hospital serving underprivileged children in the Boston area, the Institute has transformed its mission to center around three pillars: biological research, clinical service, public health outreach, and technological innovation.

By merging the ADA Science & Research Institute and the Forsyth Institute, the new establishment promises to revolutionize the landscape of oral health research and innovation.

New ADA Forsyth Institute Looks to Pioneer Excellence in Oral Health Research and Innovation

new launches from Kerr Dental, MGF, PreXion, ZimVie, Amann Girrbach, VOCO, ASI Dental Specialties, DMG, and NovoDynamics.

Product Bites – October 27, 2023

Welcome to Product Bites, a weekly podcast from Dental Products Report, providing you with a rundown of recently launched an updated dental technologies, materials, instruments and everything else you might use with patients or while running your practice.

I'm your host for this week, DPR Editorial Director Noah Levine and on this week's podcast, we've got a bevy of new products to talk about, including the latest from Kerr Dental, PreXion, DMG, ASI Dental Specialties, and more. So let's get to it and learn about this latest collection of new dental products.

Kerr Dental has introduced SimpliShade Bulk Fill and SimpliShade Bulk Fill Flow, 2 dental composites aimed at improving flexibility and simplicity in restorative procedures. These products, powered by Ternary Adaptive Response technology aim to deliver long lasting restorations with reduced shrinkage and enhanced strength. Both materials feature a one-shade system that matches all 16 VITA Classical shades. SimpliShade Bulk Fill can be placed in increments of up to 5 mm and it can be used without a capping layer. SimpliShade Bulk Fill Flow is a self-leveling composite providing comprehensive coverage. It also can be cured in 5 mm increments, and it should be placed beneath a capping layer.

Italian manufacturer MGF Compressors now offers a new line of IoT (Internet of Things) Compressors designed to enhance work efficiency in dental practices. These smart compressors use internet connectivity to monitor usage parameters, manage regular upkeep, and provide predictive maintenance. This technology shifts equipment service from a reactive intervention to a preventive and programmed approach, ensuring targeted, fast and efficient responses. It offers real-time monitoring and connectivity to service technicians through the MGF app.

The new Evolve Sensor from PreXion is a digital intraoral sensor that provides high definition images. This sensor is fully compatible with all x-ray equipment on the market and offers user-friendly software. The Evolve sensor connects to a computer via USB cable, and its advanced image processing provides sharp images for accurate diagnosis.

The 3-in-1 PreXion 3D Evolve CBCT - Panoramic and Cephalometric imaging system is designed to be a complete dental imaging solution that can grow with a practice while providing top of the line imaging capabilities in any of its 3 imaging modalities. In the panoramic mode, it offers multislice capability for precise visualization and optimal sharpness and contrast. The addition of the optional cephalometric arm enhances diagnostic potential with specialized imaging of hard and soft tissues.

ZimVie recently launched Azure Multi-Platform Product Solutions, a platform consisting of 13 dental laboratory focused prosthetic and restorative solutions. These solutions are designed for seamless integration into digital workflows, offering dental professionals a wide range of options for tooth replacement cases. Azure aims to simplify decision making for dental laboratories by providing high quality, profitable and well supported solutions for almost any implant case in a single place. The product range includes implant compatible prosthetics, bases, attachments, blanks, screws, and tools.

Amann Girrbach has enhanced its chairside CAD/CAM solution with the Ceramill DRS software upgrade 1.5. The upgrade includes features like faster scanning speeds and improved 3D scan display colors. The Ceramill Motion DRS milling machine now supports a broader range of materials and offers both validated and generic milling strategies. A new Ceramill DRS abutment workflow streamlines the design and milling of crowns and abutments for implant cases. The software update also includes additional features like the Artex CR virtual articulator, color visualization for natural restoration design, and simplified software installation and updates.

With the introduction of the new Admira Fusion BXL shade, there are now 19 available shades for VOCO's universal nanohybrid ORMOCER restorative material. This new bleach shade enhances the materials eesthetics and is available in both caps and syringes. Admira Fusion boasts low shrinkage, immediate esthetics, easy handling, and superior biocompatibility. It eliminates traditional monomers in the formulation and offers an optimal balance of translucency and opacity. Admira Fusion is compatible with conventional bonding agents and demonstrates high wear resistance.

ASI Dental Specialties recently introduced the GliderLite dental surgical table, designed to optimize essential material accessibility during procedures, even in smaller operatory spaces. The table is compatible with standard dental patient chairs and features a non-porous main worktop surface. It offers ample space for sterile instruments and accessories, including an optional floating instrument shelf, and dovetail rails for customization. With electrical height adjustment and programmable presets, clinicians can personalize their working positions. Integrated power outlets make it easy to keep equipment powered on as the table is moved.

DMG announced the DentaMile Desk MC system, an all in one solution for 3D printing in dental practices and small dental laboratories. The system combines a 3D printer, washing unit, and curing unit for nearly plug-and-play experience. It includes the compact DentaMile Desk MC-5 DLP printer, a washing unit with efficient preset programs, and a curing unit with Omni 360-degree technology. The system is compatible with DMG's LuxaPrint suite of 3D printing resins, offering a range of materials for various dental applications. The DentaMile Connect software streamlines 3D printing with automated nesting and slicing, and it can be accessed remotely.

Finally, the latest version of NovoHealth Dental from NovoDynamics uses artificial intelligence to automate the insurance claim verification process. It is designed to detect missing documentation and ensure that anatomical references are visible in the insurance claims prior to submission. The platform assists providers in correcting incomplete claims before payer review. It is capable of automatically recognizing attachment types, distinguishing individual views from full mouth series, identifying and labeling quadrants and teeth, and checking for compliance with payer-specific evidence requirements. It also performs clinical analyses to determine if the evidence meets payment criteria. The platform reportedly results in enhanced productivity, consistency, and cost savings for both payers and providers, leading to faster and more accurate claim decisions.

That wraps up this large load of new products for this week. Thanks for listening to Product Bites from Dental Products Report. For all things new dental products, you can always go to dentalproductsreport.com/newdentalproducts. I'm Noah Levine. And we'll be back next week with more new dental products on the next edition of Product Bites.

Podcasts

Product Bites makes sure you don't miss the next innovation for your practice. 
This week's Product Bites podcast features new launches from Kerr Dental, MGF, PreXion, ZimVie, Amann Girrbach, VOCO, ASI Dental Specialties, DMG, and NovoDynamics. [8 Minutes]

Through a new partnership, Dental Robot, an artificial intelligence (AI) platform designed to streamline insurance verification, will incorporate IntelePeer's AI-powered communications automation platform (CAP) to offer a comprehensive, self-service, omnichannel experience to patients, while also enhancing data integrity within Revenue Cycle Management (RCM).

This new service is aimed at the growing dental group practice market, according to a press release. The communications automation platform will provide Dental Robot customers with an omnichannel engagement platform encompassing messaging, chat, and email interactions between the practice and patients. The software includes virtual assistants with built-in natural language processing and generative AI capabilities to help provide automated appointment scheduling, confirmation reminders, and rescheduling for current patients as well as patients new to the practice.

The communications platform provides opportunities to automate patient interactions, and the data on the back end of the solution provides ongoing business intelligence to group dental practices. The platform integrates with CRM and other business applications and provides self-service data gathering and automated bill payment. Additionally, a practice-specific question-and-answer database can be combined with generative AI to provide robust responses to thousands of patient questions.

“By partnering with IntelePeer, we’ll continue to improve both front- and back-office experiences for dental practices nationwide,” says Dental Robot CEO Manuel Barroso. “Together, we’re enabling practices to decrease manual processes, increase staff productivity, and save hundreds of hours a week by tapping into the power of AI and automation.”

The IntelePeer platform taps into Azure's OpenAI AI engine to enable users to create dynamic patient communication workflows that can be seamlessly integrated into existing processes. Users can also create intelligent AI voice and messaging bots based on customer interactions, CRM data, and other sources. These bots can manage communications to enrich the patient experience, according to the press release.

“We’re excited to introduce the power of generative AI to the Dental Robot platform, taking the patient experience to the next level through the use of AI and automation,” says IntelePeer CEO Frank Fawzi. “Working together, IntelePeer and Dental Robot solve two major pain points for the industry–insurance processing and the ability for patients to effectively self-serve without the need of costly human intervention. By using our communications automation platform, dental practices will be able to reduce labor costs, deliver personalized communications across channels, and see a return on their investment in a matter of weeks.”

As part of this collaboration, IntelePeer and Dental Robot are set to engage in various industry events. The inaugural event, Becker's Healthcare Future of Dentistry Roundtable on Oct. 26, will feature Barroso, along with IntelePeer executives Joe Galinanes and Corbin Fields discussing the positive impact of AI and automation on the patient experience, specifically in a session titled "Streamlining Customer Service and RCM with AI Automation."

This new artificial intelligence software collaboration aims to automate and optimize patient interactions for group dental practices.

IntelePeer Partners With Dental Robot to Bring Artificial Intelligence to DSO Patient Communications

Dental practices using Carestream Dental's Sensei Cloud online practice management platform now have access to a new set of patient engagement tools through a new software integration with Intiveo.

The new connected solution allows practices to manage patient communication services including appointment reminders, two-way communication, and feedback collection from a single platform, according to a press release.

"Our mission has always been to create meaningful connections between dental practices and their patients," Josh deVries, co-founder and CEO of Intiveo says in the press release. "That's why we are so excited to bring this integration to market with the Sensei team to help dental practices elevate patient satisfaction and experience. This collaboration magnifies our reach, ensuring more patients benefit from streamlined communication and top-tier patient experience."

The software integration was reportedly spurred by requests from customers of both platforms demanding advanced ways to manage the patient experience at their practices. Customers of both Intiveo and Sensei can access this integrated software solution now.

Founded in 2010, Intiveo is a Vancouver, Canada-based software company focused on dental patient communication solutions. The company first established itself as a communication solution for dental schools and later expanded to provide patient engagement solutions for private dental practices. The platform provides tools designed to automate workflows to save staff time while helping the practice optimize its operations with metrics on all programs available to help practices track what is working and what is not.

With this integrated solution, practices using the Sensei platform can seamless work with Intiveo's patient engagement tools.

Intiveo Patient Engagement Solution Now Integrates with Carestream Dental's Sensei Cloud Practice Management Platform

Denti.AI Revolutionizes Pathology Detection with FDA Clearance for Denti.AI Detect | Image Credit: © Denti.AI 

Denti.AI, a trailblazer in the realm of artificial intelligence- (AI-) driven dental pathology detection, odontogram, and periodontal charting automation, today announced the monumental achievement of securing FDA 510(k) clearance for its groundbreaking product, Denti.AI Detect. This state-of-the-art AI-powered imaging solution is set to redefine disease detection capabilities in both intraoral and extraoral dental radiography, while also automating charting processes.

Denti.AI Detect has been designed to empower dental professionals with the ability to identify prevalent dental diseases, such as caries, periapical lesions, and bone loss, using dental x-rays. Extensive clinical studies with the participation of over 2 dozen dentists have demonstrated a notable enhancement in disease detection, unlocking an impressive 26% increase in treatment opportunities when using Denti.AI Detect.

This milestone follows the successful clearance of Denti.AI Auto-Chart in November 2022, a breakthrough in automating odontogram charting for various dental procedures, including restorations, root canals, implants, crowns, and missing teeth. Denti.AI Detect seamlessly integrates with Auto-Chart to further streamline disease charting and treatment plan coding in multiple integrated practice management systems. This integration marks a significant stride towards optimizing dental practice workflows and enhancing patient care.

One of the key distinguishing features of Denti.AI Detect is its industry-first FDA clearance for disease detection on panoramic images, a significant advancement in dental radiography. Denti.AI holds the unique distinction of being the only dental AI company to have secured clearance for all 3 major dental concerns: caries, periapical radiolucencies, and bone levels, making it a transformative player in the dental technology landscape, according to the company.

Edward Gelfand, DDS, owner of over 30 dental practices and a partner of the largest Canadian Dental Service Organization (DSO), praised the effectiveness of Denti.AI Detect, saying in a press release, "The ability of Denti.AI Detect to uncover missed diseases has been a game-changer in not only identifying treatment opportunities but also in educating our patients. Our best dentists attest to the indispensable nature of this tool in their practice."

Before receiving FDA clearance, Denti.AI Detect had already obtained licensing from Canada Health and had been extensively utilized across multiple dental practices in Canada, underscoring its practical utility and reliability. Jonathan B. Levine, DMD, owner of the prestigious multi-specialty clinic JBL NYC and chairman/founder of innovative dental technology company GLOScience, shared his positive experience, stating in the press release, "After rigorous research of Denti.AI Detect in our clinic over many months, I am thrilled to finally become a customer. The technology has proven itself invaluable."

Denti.AI's Founder and CEO, Dmitry Tuzoff, reflected on the journey, stating in the press release, "The realization of Denti.AI Detect clearance signifies countless hours of dedication from our team. The introduction of panoramic imaging technology, especially, propels our product to the forefront, addressing the growing usage of such imaging practices across North America."

To celebrate this big achievement, Denti.AI is offering special pricing terms for Denti.AI Detect and Auto-Chart until the end of the year. Interested parties are encouraged to explore this opportunity by filling out the form at www.denti.ai.

Established in 2017, Denti.AI employs AI to decipher pathologies, past treatments, and anatomical features from dental x-rays and voice commands, facilitating early disease detection, enhancing productivity for dentists and hygienists, and ensuring accurate record-keeping. Integrated with practice management systems, Denti.AI's imaging and voice AI products are automating workflows for dental groups across North America, boasting hundreds of active users.

The company receives FDA 510(k) clearance of Denti.AI Detect, a revolutionary AI-powered imaging solution, amplifying disease detection capabilities in intra- and extraoral dental radiography and charting automation.

 Denti.AI Revolutionizes Pathology Detection with FDA Clearance for Denti.AI Detect

New Suite of Products from ClearCorrect Designed to Elevate Orthodontic Offerings | Image Credit: © ClearCorrect

Clear aligner solutions provider ClearCorrect® has launched a series of new orthodontic solutions and innovations to the global market.

The Round Rock, Texas-based company is working to elevate dental and orthodontic practices, allowing clinicians to achieve their desired treatment results for an expanded group of treatable patients. ClearCorrect supports clinicians in their treatment of malocclusion, and these latest offerings feature key updates made to the Premier Aligner, Digital Workflow, and Practice Growth offerings.

“ClearCorrect® is thrilled to launch these new solutions and features globally. Our latest wave of innovations allows clinicians to treat more complex cases, and we will continue to work together in partnership with clinicians to bring healthier, more confident smiles to patients,” Laura Sterling, Head of Global Marketing and Education, says in a press release.

In an effort to further strengthen its partnership with clinicians, ClearCorrect is making more resources and tools available to practices and their teams through the 

, a newly assembled suite of marketing, education, and business resources designed to empower clinicians and staff to grow their practice together and convert patients to ClearCorrect with confidence.

Combining clinical expertise, with a commitment to education and a dedication to top-tier support, the company offers clinicians a partnership in orthodontics designed to help them unlock the potential of their practice, and ultimately their patients’ lives.

A pair of 2 new ClearControl™ Clinical Features introduced are designed to empower clinicians to treat more patients. Optimized and patented* for the ClearCorrect® system, 

 feature an innovative 3-arch design that will enable the treatment of crossbite cases.

 has been unveiled and it is said to enable a more efficient and precise engager placement. Featuring a thinner and more flexible material and a low and flat trimline, this new Engager Template is expected to begin rolling out in November, according to the company.

Additionally, 3 optimized solutions have also been launched globally to improve the integrated and intuitive software platforms—continuing ClearCorrect’s commitment to clinical digitalization and efficient digital workflows.

 feature delivers increased flexibility to clinicians designed to meet individual patient needs. This differentiating feature is designed to give clinicians the option to easily upgrade plans at any time during treatment directly in the Doctor Portal. The Doctor Portal has also been revamped with a 

, including an improved dashboard and optimized case list, that adapts to any practice workflow and allows users to easily organize and manage their clear aligner business.

 provides clinicians more control over their treatment plans and includes features that make for a more efficient treatment planning experience. It uses visualization tools like Bite Jump Simulation, advanced editing tools for arch adjustment, additional ClearControl Clinical Feature controls, and user interface improvements to simplify building and evaluating treatment plans.

ClearCorrect supports clinicians in their treatment of malocclusion, and these latest offerings feature key updates made to the Premier Aligner, Digital Workflow, and Practice Growth offerings. | Image Credit: © ClearCorrect

Since being acquired by Straumann Group in 2017, ClearCorrect has significantly accelerated its software and product development activities, solidifying its position as a leader in clear aligner manufacturing and distribution, the company states. All of the recently launched innovations have been developed in collaboration with clinicians, helping to elevate their practices to achieve their full potential.

The Straumann Group is a global leader in tooth replacement and orthodontic solutions. The company unites global and international brands in replacement, corrective, and digital dentistry including Anthogyr, ClearCorrect, Dental Wings, Medentika, Neodent, NUVO, Straumann, and other fully or partly owned companies and partners.

Company’s global launch features innovations made to its Premier Aligner product and supporting software, including the Doctor Portal, and ClearPilot™ treatment viewing platform.

New Suite of Products from ClearCorrect Designed to Elevate Orthodontic Offerings

Premier Dental’s New Two Striper Perforated Diamond Finishing Strips Offered in 2 Versions  | Image Credit: © Premier Dental Co.

Premier® Dental’s newTwo Striper® Perforated Diamond Finishing Strips are designed to assist in debris removal during interproximal reduction, shaping, and contouring. Two Striper® Perforated Diamond Finishing Strips are presented in 2 versions: an uncoated safe center for easy access through the contact point, and a serrated center to facilitate access in tight spaces between teeth.

The new finishing strips are available in 10 packs of each grit or an assorted pack.

The hand-held autoclavable stainless steel perforated diamond finishing instruments are designed for interproximal reduction, shaping, and contouring. The perforations assist in debris removal.

Perforated Strip – Features an uncoated safe center for easy access through the contact point

Combo-Strip – Includes a serrated center to facilitate access in tight spaces between teeth

The Perforated option includes 2 widths – 2.50mm & 3.75mm, and 3 grits – ultra-fine, fine & medium. The Perforated Assorted option contains: (2) 300 Fine, (2) 300 Medium, (1) 300 Ultra-Fine, (2) 350 Fine, (2) 350 Medium, and (1) 350 Ultra-Fine.

The Combo-strip (perforated & serrated) option, includes1 width, and 3 grits – ultra-fine, fine & medium, while the Combo-Strip Assorted pack contains: (4) 350 Fine, (3) 350 Medium, and (3) 350 Ultra-Fine.

The hand-held autoclavable stainless steel perforated diamond finishing instruments are designed to assist in debris removal during interproximal reduction, shaping, and contouring.

Premier Dental’s New Two Striper Perforated Diamond Finishing Strips Offered in 2 Versions

A new line of composites from Kerr Dental. 

SimpliShade Bulk Fill & Bulk Fill Flow from Kerr Dental

IoT Compressors from MGF Compressors

Evolve Sensor from PreXion

Evolve CBCT, PAN and CEPH from PreXion

Azure Multi-Platform Product Solutions from ZimVie

Ceramill DRS Software Upgrade 1.5 from Amann Girrbach

Admira Fusion BXL from VOCO America

GliderLite from ASI Dental Specialties

DentaMile Desk MC System from DMG

NovoHealth Dental from NovoDynamics, Inc

New Dental products - October 16 - October 20, 2023

The latest dental products including new launches from Kerr, PreXion, ZimVie, and more.

New Dental Products - October 16 - October 20, 2023

NovoDynamics, a leading provider of artificial intelligence (AI) solutions for the dental industry, just announced the commercial deployment of the latest version of NovoHealth Dental. This cutting-edge technology is designed to transform the insurance claim verification process by automating the detection of missing documentation, such as x-ray images, charts, and correspondence, based on payer-specific guidelines for dental procedure codes.

NovoHealth Dental also ensures that the anatomical references in the claim are clearly visible in attached images, alerting dental offices promptly if any essential documentation is missing. This dental AI helps providers correct incomplete insurance claims prior to payer review.

“NovoHealth Dental’s pre-emptive claim quality and veriﬁcation approach saves both payers and providers signiﬁcant time, eﬀort, and costs,” says NovoDynamics Dental Director Joseph Borg, DDS, in a press release. “And, by adding intelligent automation early in the claim submission workﬂow, NovoHealth Dental Claim Quality Assurance also brings greater consistency and transparency to the system, making it easier for dentists and their patients to know when their claims qualify for payment.”

Historically, insurance personnel have had the challenging task of manually assessing claim attachments for the required clinical review images. With the enormous volume of submissions, clinicians could only inspect a small fraction, leading to incomplete claims being either paid or causing delays in the review process. This resulted in unnecessary costs and inconsistencies in payment outcomes.

NovoHealth Dental Claim Quality Assurance automatically:

Recognizes and classiﬁes attachment types, distinguishing between radiographs (x-ray images), photographs, charts, and correspondence.

Separates individual views from full-mouth series and speciﬁes each image as bitewing, periapical, or panoramic.

Identiﬁes and labels quadrants and teeth and ascertains if the necessary anatomy is visible.

• Determination of compliance with the specific evidence requirements outlined by the payer, with prompt notifications to dental offices for unfulfilled claim requirements.

Additionally, NovoHealth Dental goes beyond assessing completeness by also performing clinical analyses to ascertain if the evidence provided meets the criteria for payment based on the insurer's guidelines. Moreover, the system can identify potentially questionable submissions. When a claim adheres to the payer's standards, it can be expedited for auto-adjudication. In cases where NovoHealth Dental raises concerns that may warrant denial, it annotates, flags, prioritizes, and automatically routes the claim for clinician review. This approach results in enhanced review productivity, consistency, and cost savings for payers, as well as faster, more accurate, and more predictable claim decisions for providers and their patients.

NovoDynamics, with its extensive experience in AI, has consistently delivered solutions that address critical healthcare challenges, streamline processes for payers and providers, and enhance the quality of patient care. As an In-Q-Tel portfolio company, NovoDynamics has been leveraging its AI expertise and advanced image processing technology to tackle complex issues for governments, commercial enterprises, and academic institutions since 2001.

The platform, which uses NovoDynamics AI to automatically analyze dental insurance claims in real time at enterprise scale, allows NovoHealth Dental to quickly assure claim quality; accurately support clinical assessments; and reliably detect fraud, waste, and abuse.

The new solution uses dental AI to help providers correct incomplete insurance claims prior to payer review.
